Gene · 57192
Papers1,559
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,559
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Flufenamic acid inhibits pyroptosis in ischemic flaps via the AMPK-TRPML1-Calcineurin signaling pathway. | Burns Trauma | 2025 | 40655077 | PubTator, text mining | PubMed |
| Deciphering Allosteric Disease Mutations Through Intrinsic Dynamics. | J Mol Biol | 2025 | 40617464 | PubTator, text mining | PubMed |
| Synergistic Autophagy-Related Mechanisms of Protection Against Brain Aging and AD: Cellular Pathways and Therapeutic Strategies. | Pharmaceuticals (Basel) | 2025 | 40573225 | PubTator, text mining | PubMed |
| Lysosomal Acidification: A New Perspective on the Pathogenesis and Treatment of Pulmonary Fibrosis. | Compr Physiol | 2025 | 40534185 | PubTator, text mining | PubMed |
| High throughput cryo-EM provides structural understanding for modulators of the lysosomal ion channel TRPML1. | Structure | 2025 | 40532704 | PubTator, text mining | PubMed |
| DMXL1 promotes recruitment of V1-ATPase to lysosomes upon TRPML1 activation. | Nat Struct Mol Biol | 2025 | 40527988 | PubTator, text mining | PubMed |
| TRPML2 in distinct states reveals the activation and modulation principles of the TRPML family. | Nat Commun | 2025 | 40527873 | PubTator, text mining | PubMed |
| Exploring human plasma proteomic variations in mucolipidosis type IV. | Mol Ther Methods Clin Dev | 2025 | 40486934 | PubTator, text mining | PubMed |
| Lysosomal ion channels and pain. | Pain Rep | 2025 | 40486922 | PubTator, text mining | PubMed |
| Calcium-iron crosstalk in epileptogenesis: Unraveling mechanisms and therapeutic opportunities. | Neurobiol Dis | 2025 | 40480423 | PubTator, text mining | PubMed |
| RETRACTION: MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma. | Dis Markers | 2025 | 40435332 | PubTator, text mining | PubMed |
| Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future Directions. | Biomedicines | 2025 | 40426881 | PubTator, text mining | PubMed |
| MCOLN1/TRPML1-MCOLN3/TRPML3 heteromer and its coupling to Ca2+ sensor SYT5 regulates autophagosome-lysosome fusion in a PtdIns4P-dependent manner. | Autophagy | 2025 | 40413756 | PubTator, text mining | PubMed |
| Lysosomal Ion Channels and Transporters: Recent Findings, Therapeutic Potential, and Technical Approaches. | Bioelectricity | 2025 | 40342936 | PubTator, text mining | PubMed |
| NSP6 of SARS-CoV-2 Dually Regulates Autophagic-Lysosomal Degradation. | Int J Mol Sci | 2025 | 40332329 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels in Prostate Cancer: Associations with ERG Fusions and Survival. | Int J Mol Sci | 2025 | 40332161 | PubTator, text mining | PubMed |
| The synthetic TRPML1 agonist ML-SA1 mitigates intracellular lipid accumulation induced by antipsychotics in vitro by stimulating release of extracellular microvesicles. | Biochim Biophys Acta Mol Cell Biol Lipids | 2025 | 40222411 | PubTator, text mining | PubMed |
| 3,4-Dimethoxychalcone alleviates limb ischemia/reperfusion injury by TFEB-mediated autophagy enhancement and antioxidative response. | FASEB J | 2025 | 40162605 | PubTator, text mining | PubMed |
| Investigation of dynamic regulation of TFEB nuclear shuttling by microfluidics and quantitative modelling. | Commun Biol | 2025 | 40089585 | PubTator, text mining | PubMed |
| TRPML1 ion channel promotes HepaRG cell differentiation under simulated microgravity conditions. | NPJ Microgravity | 2025 | 40089547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57192/papers?page=5